Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report.

作者信息

Culebras A, Alió J, Herrera J L, López-Fraile M I

出版信息

Arch Neurol. 1981 Feb;38(2):133-4. doi: 10.1001/archneur.1981.00510020091017.

DOI:10.1001/archneur.1981.00510020091017

PMID:6781454

Abstract

摘要

相似文献

Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report.

Arch Neurol. 1981 Feb;38(2):133-4. doi: 10.1001/archneur.1981.00510020091017.

Clinical trial of an aldose reductase inhibitor in diabetic neuropathy.

Diabetes. 1981 Jun;30(6):459-64. doi: 10.2337/diab.30.6.459.

[Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].

Ugeskr Laeger. 1987 Nov 9;149(46):3111-4.

Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

J Neurol Neurosurg Psychiatry. 1981 Nov;44(11):991-1001. doi: 10.1136/jnnp.44.11.991.

Can aldose reductase inhibition ameliorate diabetic neuropathy?

JAMA. 1981 Sep 11;246(11):1169-70. doi: 10.1001/jama.1981.03320110003001.

Aldose reductase inhibition: studies with alrestatin.

Metabolism. 1979 Apr;28(4 Suppl 1):471-6. doi: 10.1016/0026-0495(79)90059-3.

The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.

Diabetes. 1982 Sep;31(9):789-94. doi: 10.2337/diab.31.9.789.

Aldose reductase inhibition for diabetic neuropathy.

Lancet. 1983 Oct 22;2(8356):969.

Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.

Am J Med. 1985 Nov 15;79(5A):13-7. doi: 10.1016/0002-9343(85)90505-4.

Pharmacological inhibition of aldose reductase in human diabetic neuropathy.

Drugs. 1986;32 Suppl 2:23-9. doi: 10.2165/00003495-198600322-00007.

引用本文的文献

The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Drugs Aging. 1995 Jan;6(1):9-28. doi: 10.2165/00002512-199506010-00002.

Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

J Neurol Neurosurg Psychiatry. 1981 Nov;44(11):991-1001. doi: 10.1136/jnnp.44.11.991.

Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Diabetologia. 1983 Oct;25(4):365-71. doi: 10.1007/BF00253203.

Ganglioside treatment in diabetic peripheral neuropathy: a multicenter trial.

Acta Diabetol Lat. 1983 Jul-Sep;20(3):265-76. doi: 10.1007/BF02581271.

Diabetic neuropathies. Current concepts in prevention and treatment.

Drugs. 1986 Sep;32(3):279-89. doi: 10.2165/00003495-198632030-00004.

Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.

Drugs. 1987;33 Suppl 2:125-30. doi: 10.2165/00003495-198700332-00023.

Aldose reductase inhibitors and late complications of diabetes.

Drugs. 1986;32 Suppl 2:43-55. doi: 10.2165/00003495-198600322-00010.

Treatment of peripheral neuropathies.

J Neurol Neurosurg Psychiatry. 1985 Dec;48(12):1193-207. doi: 10.1136/jnnp.48.12.1193.

Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence.

Drugs. 1990 Feb;39(2):190-202. doi: 10.2165/00003495-199039020-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验